Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 15

1.

Serum microRNA-21 as a potential biomarker for response to hypomethylating agents in myelodysplastic syndromes.

Kim Y, Cheong JW, Kim YK, Eom JI, Jeung HK, Kim SJ, Hwang D, Kim JS, Kim HJ, Min YH.

PLoS One. 2014 Feb 4;9(2):e86933. doi: 10.1371/journal.pone.0086933. eCollection 2014.

PMID:
24503739
[PubMed - in process]
Free PMC Article
2.

Sequential treatment with cytarabine and decitabine has an increased anti-leukemia effect compared to cytarabine alone in xenograft models of childhood acute myeloid leukemia.

Leonard SM, Perry T, Woodman CB, Kearns P.

PLoS One. 2014 Jan 28;9(1):e87475. doi: 10.1371/journal.pone.0087475. eCollection 2014.

PMID:
24489920
[PubMed - in process]
Free PMC Article
3.

Combined treatment with low concentrations of decitabine and SAHA causes cell death in leukemic cell lines but not in normal peripheral blood lymphocytes.

Brodská B, Holoubek A, Otevřelová P, Kuželová K.

Biomed Res Int. 2013;2013:659254. doi: 10.1155/2013/659254. Epub 2013 Aug 13.

PMID:
24000324
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

The myelodysplastic syndrome as a prototypical epigenetic disease.

Issa JP.

Blood. 2013 May 9;121(19):3811-7. doi: 10.1182/blood-2013-02-451757. Review.

PMID:
23660859
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Epigenetic modification of the Epstein-Barr virus BZLF1 promoter regulates viral reactivation from latency.

Murata T, Tsurumi T.

Front Genet. 2013 Apr 9;4:53. doi: 10.3389/fgene.2013.00053. eCollection 2013.

PMID:
23577022
[PubMed]
Free PMC Article
6.

p53R2 expression as a prognostic biomarker in early stage non-small cell lung cancer.

Hsu NY, Wu JY, Liu X, Yen Y, Chen CY, Chou MC, Lee H, Cheng YW.

Oncol Lett. 2010 Jul;1(4):609-613. Epub 2010 Jul 1.

PMID:
22966352
[PubMed]
Free PMC Article
7.

Epigenetic therapies in MDS and AML.

Griffiths EA, Gore SD.

Adv Exp Med Biol. 2013;754:253-83. doi: 10.1007/978-1-4419-9967-2_13. Review.

PMID:
22956506
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Synergism between clofarabine and decitabine through p53R2: a pharmacodynamic drug-drug interaction modeling.

Thudium KE, Ghoshal S, Fetterly GJ, Haese JP, Karpf AR, Wetzler M.

Leuk Res. 2012 Nov;36(11):1410-6. doi: 10.1016/j.leukres.2012.07.015. Epub 2012 Aug 9.

PMID:
22884950
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

The effects of promoter methylation on downregulation of DAZAP2 in multiple myeloma cell lines.

Luo SQ, Hu JP, Qu Q, Li J, Ren W, Zhang JM, Zhong Y, Hu WX.

PLoS One. 2012;7(7):e40475. doi: 10.1371/journal.pone.0040475. Epub 2012 Jul 9.

PMID:
22792345
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

The depletion of DNA methyltransferase-1 and the epigenetic effects of 5-aza-2'deoxycytidine (decitabine) are differentially regulated by cell cycle progression.

Al-Salihi M, Yu M, Burnett DM, Alexander A, Samlowski WE, Fitzpatrick FA.

Epigenetics. 2011 Aug;6(8):1021-8. doi: 10.4161/epi.6.8.16064. Epub 2011 Aug 1.

PMID:
21725200
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Opposing roles of Dnmt1 in early- and late-stage murine prostate cancer.

Kinney SR, Moser MT, Pascual M, Greally JM, Foster BA, Karpf AR.

Mol Cell Biol. 2010 Sep;30(17):4159-74. doi: 10.1128/MCB.00235-10. Epub 2010 Jun 28.

PMID:
20584988
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Leukaemogenesis: more than mutant genes.

Chen J, Odenike O, Rowley JD.

Nat Rev Cancer. 2010 Jan;10(1):23-36. doi: 10.1038/nrc2765. Review.

PMID:
20029422
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

High DNA methyltransferase 3B expression mediates 5-aza-deoxycytidine hypersensitivity in testicular germ cell tumors.

Beyrouthy MJ, Garner KM, Hever MP, Freemantle SJ, Eastman A, Dmitrovsky E, Spinella MJ.

Cancer Res. 2009 Dec 15;69(24):9360-6. doi: 10.1158/0008-5472.CAN-09-1490. Epub .

PMID:
19951990
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

5-azacitidine prolongs overall survival in patients with myelodysplastic syndrome--a systematic review and meta-analysis.

Gurion R, Vidal L, Gafter-Gvili A, Belnik Y, Yeshurun M, Raanani P, Shpilberg O.

Haematologica. 2010 Feb;95(2):303-10. doi: 10.3324/haematol.2009.010611. Epub 2009 Sep 22.

PMID:
19773261
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Enzymology of purine and pyrimidine antimetabolites used in the treatment of cancer.

Parker WB.

Chem Rev. 2009 Jul;109(7):2880-93. doi: 10.1021/cr900028p. Review. No abstract available.

PMID:
19476376
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk